iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

A Prospective Evaluation of the Second Generation iStent Inject in Open-Angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications. Outcomes will be evaluated at 12 and 24 months.

Inclusion Criteria:

• Diagnosed with primary open angle glaucoma (POAG)
• Subject on two ocular hypotensive medications

Exclusion Criteria:

• Traumatic, uveitic, neovascular, or angle closure glaucoma
• Fellow eye already enrolled